Jul 24 |
(LGVN) - Analyzing Longeveron's Short Interest
|
Jul 19 |
Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
Jul 18 |
Longeveron slides on $9M stock offering
|
Jul 18 |
Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
|
Jul 17 |
Longeveron stock rallies 19% on Alzheimer's drug update
|
Jul 17 |
Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mild Alzheimer’s Disease
|
Jul 17 |
LGVN Gets Great FDA News for Alzheimer's Drug
|
Jul 17 |
7 Meme Stocks That Deserve a Fresh Set of Eyes
|
Jul 15 |
OTC Markets Hosts Virtual Investor Presentation with Wa’el Hashad, CEO of Longeveron, and Brad Sorensen, Senior Analyst at Zacks SCR
|
Jul 10 |
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|